-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OAVDOvjziQIrnWXdNVJZWvFGmZ4JzNgnJ+4aZ/cYpIA+pMhjWyHHJMkrGCdHIcX1 ousHVkfthTkK0bIlyY+DHw== 0001285101-07-000002.txt : 20070507 0001285101-07-000002.hdr.sgml : 20070507 20070507110947 ACCESSION NUMBER: 0001285101-07-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070504 FILED AS OF DATE: 20070507 DATE AS OF CHANGE: 20070507 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHANNON COLIN CENTRAL INDEX KEY: 0001285101 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 07822680 BUSINESS ADDRESS: BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 3151 SOUTH 17TH ST. CITY: WILMINGTON STATE: NC ZIP: 28412 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-05-04 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001285101 SHANNON COLIN 216 GATEFIELD DRIVE WILMINGTON NC 28412 0 1 0 0 EVP, Global Clinical Ops Common Stock 2007-05-04 4 M 0 9667 15.43 A 9667 D Common Stock 2007-05-04 4 S 0 6800 35.12 D 2867 D Common Stock 2007-05-04 4 S 0 1300 35.17 D 1567 D Common Stock 2007-05-04 4 S 0 900 35.13 D 667 D Common Stock 2007-05-04 4 S 0 246 35.14 D 421 D Common Stock 2007-05-04 4 S 0 83 35.15 D 338 D Common Stock 2007-05-04 4 S 0 338 35.16 D 0 D Stock Options (to buy) 15.43 2007-05-04 4 M 0 9667 0 D 2007-03-04 2014-03-03 Common Stock 9667 0 D Stock Options (to buy) 21.19 2006-11-16 2014-11-15 Common Stock 65000 65000 D Stock Options (to buy) 17.15 2007-07-16 2014-07-15 Common Stock 20000 20000 D Stock Options (to buy) 34.62 2007-02-22 2016-02-21 Common Stock 40000 40000 D 13,333 options are vested and exercisable on 2/22/07; 13,333 options are vested and exercisable on 2/22/08; and 13,334 options are vested and exercisable on 2/22/09. Lisa C. Noecker attorney-in-fact for Colin Shannon 2007-05-07 -----END PRIVACY-ENHANCED MESSAGE-----